New Zealand formally approves use of Pfizer/BioNTech vaccine

    New Zealand‘s Government granted (10-Feb-2021) formal approval for the use of the Pfizer/BioNTech vaccine in the country. COVID-19 Response Minister Chris Hipkins stated the government has secured up to 750,000 courses of the Pfizer vaccine through an advance purchase agreement, adding: “We are seeking a further small allocation through the COVAX Facility”. New Zealand will commence by vaccinating border workers, followed by security staff, customs and border officials, airline staff and hotel workers.

    We use cookies and other web technologies to collect anonymous data about the usage of this website so that we can better serve your needs. If you'd like more information on this data please see our Privacy Settings. By clicking "I Agree" below, you are agreeing to allow us to collect additional usage data.